Table 1.
Literature review of Studies on Granular Cell Tumor between 1980 and 2018
| Author | Title | Journal | Year | Findings |
|---|---|---|---|---|
| Mirza FN, Tuggle CT, Zogg CK, Mirza HN, Narayan D | Epidemiology of Malignant Cutaneous Granular Cell Tumors: A United States population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database | J Am Acad Dermatol | 2018 | DSS for local, regional and distant mGTC: 20yrs, < 5 yrs, < 0.5yrs respectively |
| Moten AS, Movva S, von Mehren M, Wu H, Esnaola NF, Reddy SS, Farma JM | Granular cell tumor experience at a comprehensive cancer center | J Surg Res | 2018 | Institutional review of 50 GTC patients: 4% malignancy rate, 6% multifocal on presentation |
| Moten AS, Zhao H, Wu H, Farma JM | Malignant granular cell tumor: Clinical features and long-term survival | J Surg Oncol | 2018 | 113 mGCT patients: 4.0 cm average T size, 13% lymph node metastasis, 11% distal metastasis, poorer survival in patients with T size > 5 cm |
| Imanishi J, Yazawa Y, Saito T, Shimizu M, Kawashima H, Ae K, Matsumine A, Torigoe T, Sugiura H, Joyama S | Atypical and malignant granular cell tumors in Japan: a Japanese musculoskeletal oncology group (JMOG) study | Int J Clin Oncol | 2016 | 18 atypical & mGCTs reviewed: lymph node metastasis in 4/18 cases; 5 & 10 yr OS 52%, 26% respectively. 5 yr LRFS 69% with wide resection and 43% with marginal or intralesional resection |
| Fanburg-Smith JC, Meis-Kindblom JM, Fante R, Kindblom LG | Malignant granular cell tumor of soft tissue: diagnostic criteria and clinicopathologic correlation | Am J Surg Pathol | 1998 | Reviewed 46 mGCT, 21 atypical GCT, 6 GCT: median T size in mGCT 4 cm, 1.5 cm in atypical and 2 cm in benign. 39% of mGCT died of disease at 3 yr median, local recurrence in 32%, metastasis in 50% (including lymph nodes) |
| Lack EE, Worsham GF, Callihan MD, Crawford BE, Klappenbach S, Rowden G, Chun B | Granular cell tumor: A clinicopathologic study of 110 patients | J Surg Onc | 1980 | Review of 110 GTC patients: 10% “clinically simulated a malignant neoplasm”-non pathologic diagnosis of mGTC, 5% multifocal on presentation |